Hologram Burn Dressing on Pain, Anxiety, Fear, Patient Satisfaction, and Physiological Parameters

Burn injuries represent a major global health concern, resulting in substantial physical, psychological, and social burden for individuals. Among the therapeutic procedures applied in burn care, dressing changes are consistently reported as one of the most painful and anxiety-inducing interventions. These procedures may negatively influence treatment adherence, prolong recovery, and reduce the overall quality of life for patients. While pharmacological agents are commonly administered to reduce pain and anxiety during burn dressing, they may fail to provide adequate relief and can be associated with undesirable side effects and drug dependency risks. Therefore, there is a growing emphasis on complementary, non-pharmacological strategies that can enhance patient comfort and procedural tolerance.

With rapid advances in digital health technologies, immersive visual distraction methods such as virtual reality (VR), augmented reality (AR), and hologram-based systems have emerged as novel interventions in clinical settings. Hologram technology, which presents interactive three-dimensional images, may effectively shift the patient's focus away from traumatic procedures and reduce negative emotional responses. This innovative technique has the potential to minimize pain, anxiety, and fear by engaging cognitive and sensory pathways associated with distraction. Despite its promising nature, current scientific evidence regarding hologram applications during burn dressing changes remains limited, and there is a lack of controlled clinical trials evaluating its efficacy.

This randomized controlled study aims to investigate the effects of hologram application during burn dressing procedures on pain, anxiety, fear, patient satisfaction, and physiological responses. The study will be conducted with 70 patients receiving treatment at the Burn Center of Erzurum City Hospital. Participants will be randomly assigned to the experimental group, in which hologram technology will be applied during dressing changes, or to the control group receiving standard care. Data will be collected using validated tools including the Visual Analogue Scale (VAS) for pain and satisfaction, the Burn Specific Pain Anxiety Scale, the State-Trait Anxiety Inventory (STAI), fear assessment through VAS, and physiological monitoring forms for parameters such as heart rate, respiratory rate, and blood pressure. The research will be carried out between November 2025 and May 2026.

The findings of this study are expected to contribute high-quality evidence on the impact of hologram-based distraction as a non-pharmacological intervention in burn care. Results may support the integration of hologram technology into clinical practice to promote patient comfort, reduce emotional distress, and enhance overall treatment experience during burn dressing procedures.

Inclusion criteria

• Between the ages of 18-65,
• Able to read, write, and speak Turkish,
• Not participating in any other clinical research at the same time,
• Patients without epilepsy who have been admitted to the burn unit for treatment,
• Non-infected cases,
• Patients who have not undergone minor and/or major surgical procedures (fasciotomy, escharotomy, amputation, etc.) that may affect the wound healing process,
• Without any cognitive, affective, or other problems that may prevent them from communicating verbally and understanding information,
• Total body surface area (TBSA) of burns is less than 20% of the second degree; Patients with a 3rd degree burn below 15% (20% in 2nd degree patients; sedation required in 3rd degree patients above 15%),
• 2nd and 3rd degree burns in the granulation stage (2nd and 3rd degree burns requiring treatment and high pain levels),
• Not affected by different non-drug treatment methods that would affect pain,
• Undergoing standard analgesia protocol,
• No burns on the head, ears, or face,
• Burns of hot liquid contact (scald),
• Patients whose initial burn dressing was performed at the burn center where the study was conducted, with dressing changes every two days and at least two consecutive dressing changes were included in the study.

Exclusion criteria

• Patients who developed any complications during two consecutive dressing changes (sepsis, fever, hemodynamic instability, wound infection, new trauma to the burn area, or conditions requiring additional surgical intervention, etc.),
• Patients diagnosed with epilepsy were excluded from the study due to the risk of seizure triggering by photosensitive stimuli.